Status:
COMPLETED
Mobile Attentional Bias Modification Training in Pediatric MS
Lead Sponsor:
NYU Langone Health
Conditions:
Pediatric Multiple Sclerosis
Eligibility:
All Genders
12-24 years
Phase:
NA
Brief Summary
This study will examine the feasibility of using a mobile ABMT application as a treatment modality in the Pediatric Multiple Sclerosis population. Participants will be asked to undergo one hour-long b...
Eligibility Criteria
Inclusion
- Age 12-24 years
- Confirmed Diagnosis of Multiple Sclerosis with onset \< 17 years and 11 months (defined by the 2013 International Pediatric MS Study Group (IPMSSG) criteria (Krupp, Tardieu, Amato, Banwell, Chitnis, Dale, Ghezzi, Hintzen, Kornberg, Pohl, Rostasy, Tenembaum, Wassmer, \& Sclerosis, 2013) and the 2010 McDonald criteria (Polman et al., 2011).)
- Followed at NYU Multiple Sclerosis Comprehensive Care Center
- Access to a mobile device with iOS (devices will be provided to subjects if this criteria is not met, see section 4.4)
- Active or concurrently enrolled in the ongoing US Network of Pediatric MS Centers Study Consortium
Exclusion
- Previous report of an IQ \< 70
- Wide-Range Achievement Test-Fourth Edition (Wilkerson, 2006) Reading Subtest standard score \<85
- Non-English speaking, learned English in the past three years, or learned English after the age of 12 years
- Not willing to comply with all study procedures
- Insufficient visual and motor ability to operate the intervention and assessments
Key Trial Info
Start Date :
June 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 26 2021
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT04441229
Start Date
June 12 2020
End Date
March 26 2021
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016